Stay updated on REL-1017 Adjunctive for MDD: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the REL-1017 Adjunctive for MDD: Efficacy & Safety Clinical Trial page.

Latest updates to the REL-1017 Adjunctive for MDD: Efficacy & Safety Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2 on the page. This is a minor metadata update and does not affect study details.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page, which appears to be a backend software revision with no visible changes to the trial details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check30 days agoChange DetectedUI and labeling updates were made, including glossary display controls (Show/Hide glossary) and capitalization changes to labels (Met QC Criteria, data), along with a revision version update. These changes do not affect the study data, outcomes, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check37 days agoChange DetectedThe page now shows Revision: v3.3.4 after updating from v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedThe locations section was updated to add state locations (Florida, Georgia, Illinois, Massachusetts, Missouri, New York, Ohio, Texas). Existing state listings were removed, accompanied by a revision note.SummaryDifference1.0%

- Check87 days agoChange DetectedThe Publications section sentence was reworded from 'these publications are about the study results' to 'these publications are about the results of the study', and the revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to REL-1017 Adjunctive for MDD: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REL-1017 Adjunctive for MDD: Efficacy & Safety Clinical Trial page.